Literature DB >> 2504935

Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator.

T Neuman1, R W Stephens, E M Salonen, T Timmusk, A Vaheri.   

Abstract

Human SH-SY5Y neuroblastoma cells treated with retinoic acid, 12-O-tetradecanoyl-phorbol-13-acetate (TPA) or nerve growth factor differentiated morphologically to neuronlike cells with increased amounts of neurofilament protein and mRNA. All three effectors induced an increase in the amount of relative molecular weight (Mr) 70,000 tissue-type plasminogen activator (t-PA) and its mRNA, as determined by immunocapture, enzyme activity, and Northern blotting analyses. About 90% of the t-PA activity was secreted to the culture medium. In contrast, of the three effectors studied, only TPA induced transcription of the proto-oncogene c-fos, studied as a control gene responsive to various stimuli, and induced a rapid increase in urokinase-type PA (u-PA). Most of the u-PA activity induced by TPA remained cell-associated. Because induction of differentiation correlated closely with induction of t-PA, and not u-PA, the authors propose that t-PA may have a functional role in the morphological differentiation of neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504935     DOI: 10.1002/jnr.490230305

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

Authors:  M S Stack; S Gately; L M Bafetti; J J Enghild; G A Soff
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia.

Authors:  Susanna Benvenuti; Cristiana Deledda; Paola Luciani; Giulia Modi; Alessandro Bossio; Corinna Giuliani; Benedetta Fibbi; Alessandro Peri
Journal:  Neuromolecular Med       Date:  2013-05-22       Impact factor: 3.843

3.  Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid.

Authors:  A Whitelaw; M C Mowinckel; V Fellman; U Abildgaard
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

4.  Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid.

Authors:  Effie G Halakos; Andrew J Connell; Lisa Glazewski; Shuo Wei; Robert W Mason
Journal:  J Proteomics       Date:  2019-08-28       Impact factor: 4.044

5.  RB2/p130 ectopic gene expression in neuroblastoma stem cells: evidence of cell-fate restriction and induction of differentiation.

Authors:  F P Jori; U Galderisi; E Piegari; G Peluso; M Cipollaro; A Cascino; A Giordano; M A Melone
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

6.  Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.

Authors:  J Bizik; A Lizonová; R W Stephens; M Grófová; A Vaheri
Journal:  Cell Regul       Date:  1990-11

7.  Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.

Authors:  V M Díaz; M Hurtado; T M Thomson; J Reventós; R Paciucci
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.

Authors:  Manuel Yepes; Maria Sandkvist; Timothy A Coleman; Elizabeth Moore; Jiang-Young Wu; David Mitola; Thomas H Bugge; Daniel A Lawrence
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro.

Authors:  M E Bracke; N A Van Larebeke; B M Vyncke; M M Mareel
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

10.  Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx.

Authors:  S Parolini; D Flagiello; A Cinquetti; R Gozzi; S Cristini; J Cappiello; P Nicolai; M Rusnati; M Presta; M M Tosatti
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.